Evidence map›Paper›PMID 10639112›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Antitumorigenic actions of growth hormone-releasing hormone antagonists.

R D Kineman

Abstract readComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  12. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  13. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

R D KinemanUniversity of Illinois, Department of Medicine, Section of Endocrinology and Metabolism, Chicago, IL 60612-7333, USA. kineman@uic.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Agents, HormonalCarcinoma, Small CellCyclic AMPGrowth Hormone-Releasing HormoneHumansLung NeoplasmsMiceReceptors, NeuropeptideReceptors, Pituitary Hormone-Regulating HormoneTumor Cells, CulturedVasoactive Intestinal PeptideAntineoplastic Agents, HormonalCyclic AMPGrowth Hormone-Releasing HormoneReceptors, NeuropeptideReceptors, Pituitary Hormone-Regulating Hormonesomatotropin releasing hormone receptorVasoactive Intestinal Peptide

Identifiers

PMID10639112
PMCPMC33960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.